Status:
RECRUITING
Experience of Biologic Treatments for Severe Asthma: a Survey
Lead Sponsor:
Royal Devon and Exeter NHS Foundation Trust
Collaborating Sponsors:
University of Plymouth
University Hospital Plymouth NHS Trust
Conditions:
Severe Asthma
Eligibility:
All Genders
18+ years
Brief Summary
Severe asthma is a disease characterised by respiratory and non-respiratory symptoms. The respiratory symptoms can include breathlessness, wheeze and asthma attacks. The disease can come to dominate p...
Detailed Description
A multi-centre cross-sectional survey to retrospectively assess patients' perceptions of their responses to biologic treatments for their severe asthma. Methods A total of 400 patients will be recrui...
Eligibility Criteria
Inclusion
- Receiving a biologic treatment for at least 6 months.
- • But has not been on the treatment for longer than 18 months. Note: In clinical practice, a 12-month trial of biologic treatments is needed before a decision to stop/switch treatment is made. Therefore, our inclusion criteria will capture people who are non-responders to biologic treatments.
Exclusion
- Patients will be excluded if they are unwilling/unable to provide consent to use their data.
- Patients who have switched biologics will also be excluded.
- In the opinion of the physician responsible for the care of the patient, the patient has a condition, other than asthma which is significantly contributing to their respiratory symptoms, e.g. lung cancer, heart failure or severe COPD.
Key Trial Info
Start Date :
January 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06903780
Start Date
January 1 2025
End Date
December 31 2025
Last Update
June 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Devon University Healthcare NHS Foundation Trust
Exeter, Devon, United Kingdom, EX2 5DW